Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 30 Records) |
| Query Trace: DNA Damage and Egfr[original query] |
|---|
| The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study. American journal of hypertension 2009 May 22 (5): 552-8. Franceschini Nora, North Kari E, Arnett Donna, Pankow James S, Chung Jay H, Baird Lisa, Leppert Mark F, Eckfeldt John H, Boerwinkle Eric, Gu C Charles, Lewis Cora E, Myers Richard H, Turner Stephen T, Weder Alan, Kao W H Linda, Mosley Thomas H, Chakravarti Aravinda, Kramer Holly, Zhang Jinghui, Hunt Steven |
| Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers. Cancer research 2014 Nov 74 (21): 6071-81. Krishnan Vidhya G, Ebert Philip J, Ting Jason C, Lim Elaine, Wong Swee-Seong, Teo Audrey S M, Yue Yong G, Chua Hui-Hoon, Ma Xiwen, Loh Gary S L, Lin Yuhao, Tan Joanna H J, Yu Kun, Zhang Shenli, Reinhard Christoph, Tan Daniel S W, Peters Brock A, Lincoln Stephen E, Ballinger Dennis G, Laramie Jason M, Nilsen Geoffrey B, Barber Thomas D, Tan Patrick, Hillmer Axel M, Ng Pauline |
| MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (8): 1935-43. Arcila Maria E, Drilon Alexander, Sylvester Brooke E, Lovly Christine M, Borsu Laetitia, Reva Boris, Kris Mark G, Solit David B, Ladanyi Ma |
| Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma. Anticancer research 2017 04 37 (4): 1729-1735. Okamoto Tatsuro, Kohno Mikihiro, Ito Kensaku, Takada Kazuki, Katsura Masakazu, Morodomi Yosuke, Toyokawa Gouji, Shoji Fumihiro, Maehara Yoshihi |
| Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 10 24 (1): 209-216. Fan Yun, Zhu Xuehua, Xu Yan, Lu Xuesong, Xu Yanjun, Wang Mengzhao, Xu Haiyan, Ding Jingyan, Ye Xin, Fang Luo, Huang Zhiyu, Gong Lei, Lu Hongyang, Mao Weimin, Hu M |
| Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Molecular genetics & genomic medicine 2019 Dec e1079. Chen Zhanhong, Sun Tian, Yang Ziyan, Zheng Yabing, Yu Ruoying, Wu Xue, Yan Junrong, Shao Yang W, Shao Xiying, Cao Wenming, Wang Xiaoj |
| Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. The American journal of pathology 2019 Dec . Pichler Renate, Lindner Andrea K, Compérat Eva, Obrist Peter, Schäfer Georg, Todenhöfer Tilman, Horninger Wolfgang, Culig Zoran, Untergasser Gero |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Epigenetic Input Dictates the Threshold of Targeting of the Integrin-Dependent Pathway in Non-small Cell Lung Cancer. Frontiers in cell and developmental biology 2020 8 652. Zhang Yang, Cheng Kai, Xu Bingwei, Shi Junfeng, Qiang Jun, Shi Shujin, Yi Yuanqin, Li Hongxia, Jin Tengchuan, Guo Ruihua, Wu Yadi, Liu Zeyi, Wei Xiaowei, Huang Jian-An, Yang Xiuwei |
| Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 4 26 (14): 3649-3661. Zhang Kai, Hong Xiaohua, Song Zhengbo, Xu Yu, Li Chengcheng, Wang Guoqiang, Zhang Yuzi, Zhao Xiaochen, Zhao Zhengyi, Zhao Jing, Huang Mengli, Huang Depei, Qi Chuang, Gao Chan, Cai Shangli, Gu Feifei, Hu Yue, Xu Chunwei, Wang Wenxian, Lou Zhenkun, Zhang Yong, Liu |
| Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report. Thoracic cancer 2020 2 11 (4): 1094-1098. Tang Yong, Li Yadan, Zhang Lei, Tong Guihui, Ou Zhu'an, Wang Zhuocai, Zhang Henghui, Qiao Guib |
| Association of hOGG1-Cys variants with occurrence of p53 and EGFR deletion mutations in non-small cell lung cancer. Thoracic cancer 2020 Dec . Chen Ming-Jenn, Shen Ching-Ju, Wang Lee, Chen Po-Ming, Chen Chih-Yi, Lee Hu |
| Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in pharmacology 2021 6 12 645862. Wen Yang, Lin Anqi, Zhu Weiliang, Wei Ting, Luo Peng, Guo Linlang, Zhang Ji |
| Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy. International journal of molecular sciences 2021 6 22 (11): . Butkiewicz Dorota, Krze?niak Ma?gorzata, Gdowicz-K?osok Agnieszka, Giglok Monika, Marsza?ek-Ze?czak Ma?gorzata, Suwi?ski Raf |
| ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies. BMC cancer 2021 5 21 (1): 584. Matsumoto Akiko, Nakashima Chiho, Kimura Shinya, Sueoka Eizaburo, Aragane Nao |
| Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study. Oncology letters 2021 Apr 21 (4): 329. Zhang Hongbin, Wang Yuan, Ji Qiaoxia, Cai Hongmei, Liang Xiangcun, Xie Jiong, Li Hua, Wang Jun, Zhu Guiyun, Tian Erpeng, Zhu Lingling, Yuan Mingming, Chen Rongrong, Zhao M |
| A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement. Nature communications 2021 2 12 (1): 937. Zhang Yiqun, Chen Fengju, Donehower Lawrence A, Scheurer Michael E, Creighton Chad |
| Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 12 112 (5): 1165-1176. Li Li, Tang Shanshan, Yin Jiani C, Dong Lihua, Yang Zhe, Liu Yueping, Ma Jie, Chang Pengyu, Pang Jiaohui, Bao Hua, Mu Dianbin, Zheng Xiaoli, Aishajiang Reyida, He Kewen, Zhang Shaotong, Ni Meng, Wu Xue, Wang Xiaonan, Shao Yang, Wang Jun, Ge Hong, Yu Jinming, Yuan Shuang |
| Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma. NPJ genomic medicine 2021 Oct 6 (1): 82. Halle Mari K, Sundaresan Aishwarya, Zhang Jianqing, Pedamallu Chandra Sekhar, Srinivasasainagendra Vinodh, Blair Jessica, Brooke Dewey, Bertelsen Bjørn I, Woie Kathrine, Shrestha Sadeep, Tiwari Hemant, Wong Yick Fu, Krakstad Camilla, Ojesina Akinyemi |
| DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer. Frontiers in oncology 2021 10 11 708294. Dai Jiawei, Jiang Minlin, He Kan, Wang Hao, Chen Peixin, Guo Haoyue, Zhao Wencheng, Lu Hui, He Yayi, Zhou Caic |
| Chronic rhinosinusitis with nasal polyps does not harbor KRAS, BRAF, and EGFR mutations. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2022 Sep . da Silva Vieira Tamara, Guimarães Letícia Martins, Diniz Marina Gonçalves, Gomes-Fernandes Bianca, Anselmo-Lima Wilma Terezinha, Tamashiro Edwin, Bastos-Rodrigues Luciana, De Marco Luiz, Gomez Ricardo Santiago, Valera Fabiana Cardoso Pereira, Gomes Carolina Cavalie |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
| Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
| The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer. World journal of oncology 2022 5 13 (2): 84-95. Zhu Dao Qi, Liu Ying, Yu Zhi Jian, Zhang Ru Hua, Li Ai Wu, Gong Feng Ying, Wang Wei, Xiao Wei, Fan Q |
| Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 4 31 (7): 1450-1459. Mukherjee Semanti, Bandlamudi Chaitanya, Hellmann Matthew D, Kemel Yelena, Drill Esther, Rizvi Hira, Tkachuk Kaitlyn, Khurram Aliya, Walsh Michael F, Zauderer Marjorie G, Mandelker Diana, Topka Sabine, Zehir Ahmet, Srinivasan Preethi, Esai Selvan Myvizhi, Carlo Maria I, Cadoo Karen A, Latham Alicia, Hamilton Jada G, Liu Ying L, Lipkin Steven M, Belhadj Sami, Bond Gareth L, Gümü? Zeynep H, Klein Robert J, Ladanyi Marc, Solit David B, Robson Mark E, Jones David R, Kris Mark G, Vijai Joseph, Stadler Zsofia K, Amos Christopher I, Taylor Barry S, Berger Michael F, Rudin Charles M, Offit Kenne |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
- Page last reviewed:Feb 1, 2024
- Content source: